EIB Backs Akagera with €2M to Develop Vaccine Manufacturing in Rwanda
On the sidelines of the World Health Summit in Berlin on 14 October 2024, the European Investment Bank (EIB) announced
Read moreOn the sidelines of the World Health Summit in Berlin on 14 October 2024, the European Investment Bank (EIB) announced
Read moreOn 4 September 2024, US pharma Eli Lilly announced that it has licensed to Eva Pharma to manufacture its drug
Read moreOn 20 June 2024 in the margins of the Global Forum for Vaccine Sovereignty and Innovation in Paris, France, the
Read moreFollowing the COVID pandemic, the world has become acutely aware of the importance of Health Security and Sovereignty. In that
Read moreAfter the sharp decline in demand for COVID19 vaccine, Moderna (MRNA) has shelved its plan to build a vaccine production
Read moreAnnounced in 2021, the project of setting up a vaccine production facility in Rwanda is finally materializing in December 2023.
Read moreOn 12 December 2023, during a Board meeting of the Global Alliance for Vaccination and Immunization (#GAVI) in Accra, Ghana,
Read moreOn 26 October 2023 during the Global Gateway Forum (#GGF2023) in Brussels, the EU announced an additional EUR 500 million
Read moreDuring the COVID, several countries, including Mauritius, became acutely aware of the strategic importance of #HealthSecurity and #MedicalSovereignty as nations
Read moreBill Gates, Co-Chair of the Bill & Melinda Gates Foundation, called the attention of the world to neglected diseases such
Read more